Notice Number: NOT-DK-16-007
Key Dates
Release Date: March 9, 2016
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Purpose
In a continuing effort to support emerging fields in nonmalignant hematology research, NIDDK is pleased to announce funding and changes in the research objectives for PAS-16-033 "Stimulating Hematology Investigation: New Endeavors (R01)". This Notice provides details of the changes.
The NIDDK SHINE program (PAS-16-033) has set aside approximately $750,000 to make approximately 3-4 awards in addition to those funded in accordance with NIDDK FY 2016 funding policies. These funds will be used for highly meritorious applications received in response to PAS-16-033 in the specific scientific areas mentioned below.
(1) As announced in the inauguration of the SHINE program (PAS-10-046, the predecessor of PAS-16-033), specific topic areas will change in order to meet timely needs and opportunities for hematology research. Applicants are encouraged to contact NIDDK Scientific/Research staff to discuss plans for preparation of an R01 application.
(2) With the publication of this Notice, the following SHINE-eligible topics are encouraged:
(3) The addition of the "Effects of Aging on Hematopoiesis" topic was informed by an NIDDK-sponsored workshop held on January 28-29, 2016 in collaboration with the National Institute on Aging (NIA) and the National Heart, Lung, and Blood Institute (NHLBI). Click here to view the workshop agenda. Some examples of relevant research goals include, but are not limited to:
(4) With the publication of this Notice, June 5, 2016 (for New applications) and July 5, 2016 (For renewal, resubmission and revision applications) will be the final standard receipt dates of the SHINE topic of "Biology and Pathophysiology of Myelodysplastic Syndromes (MDS)". NIDDK Hematology program still accepts applications for this topic through the NIH "Parent" R01 FOA, PA-13-302.
Inquiries
Please direct all inquiries regarding Iron; Heme Biosynthesis; Bone Marrow Failure/Myelodysplastic Syndrome and Terminal Erythropoiesis to:
Cindy N. Roy, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8805
Email: cindy.roy@nih.gov